Atul share price & results
- Sept 2026
- Sept 2026
Integrated Indian chemical maker running 8 plants, selling 1,300+ products across 88 countries.
Price & Snapshot
Performance −7.0% 1Y
1Y: ₹5,691 on 7 Nov 2025 → ₹5,290. High ₹7,108 (6 May 2026), low ₹5,028.5 (30 Oct 2026).
- Previous close
- ₹5,295
- Market cap
- ₹15.6k Cr
- 52-week range
- ₹5,028.5 – ₹7,108
- One year
- −7.44%
- Price to earnings (TTM to Sept 2026)
- 20.17×
- Return on equity (TTM to Sept 2026)
- 11.73%
Reported
Key financial metrics & valuation ratios
Each figure keeps its basis and period; nothing is filled in.
| Metric | Value | Change | Basis | Period | Note |
|---|---|---|---|---|---|
| Revenue | 1,877 | +20.9% YoY | Quarterly, as filed | Quarter to Sept 2026 | Revenue from operations as filed. |
| Operating margin | 13.0 | −4.0 pts YoY | Operating profit / revenue | Quarter to Sept 2026 | For the quarter; a change is in percentage points. |
| Net profit | 159 | −12.6% YoY | Quarterly, as filed | Quarter to Sept 2026 | Profit after tax as filed. |
| Return on equity | 11.73 | +2.4 pts | Trailing twelve months | TTM to Sept 2026 | Adjusted profit attributable to owners ÷ average owners’ equity. |
| Free cash flow margin | 13.56 | +7.6 pts | Fiscal year | FY ending Mar 2026 | (Operating cash flow − fixed-asset purchases + disposals) ÷ revenue. |
| Revenue growth (YoY) | 18.14 | −5.8 pts | Trailing twelve months | TTM to Sept 2026 | Revenue change against the same period one year earlier. |
Business Mix
Where revenue comes from
Life Science Chemicals shrank from 31% to 24% of revenue over the last two years.
Live Summary
Overview
- Symbol
- NSE:ATUL
- Sector
- Chemicals
- Industry
- Commodities
- Exchange
- NSE
- Currency
- INR
What Atul Limited does
Based on the company's own presentations, annual report and earnings calls.
Atul is an integrated chemical manufacturer operating across two reported segments, Life Science Chemicals and Performance and Other Chemicals, covering sub-segments such as aromatics, bulk chemicals and intermediates, colors (dyes and pigments), crop protection (bulk actives and branded retail formulations), pharmaceuticals and polymers. It runs eight production sites, including its original complex at Atul, Valsad, and serves around 32 industries, from agriculture and textiles to pharmaceuticals and personal care, through roughly 4,000 customers spread across 88 countries. It earns by manufacturing and selling bulk chemical intermediates, specialty chemicals, agrochemical actives and formulations, dyes, pigments and APIs, mostly to other industrial and agricultural manufacturers. It also holds stakes in chemical subsidiaries and joint ventures such as Atul Bioscience, Amal, Anaven (with Nouryon) and Rudolf Atul Chemicals (with Rudolf GmbH) that extend its product range into related chemistries.
Segments
- Life Science Chemicals
- Performance and Other Chemicals
- Production sites
- 8
- Products and formulations
- 900 + 400
- Brands
- 142
- Customers
- 4,000
- Export countries served
- 88
- Industries served
- 32
Fundamentals
Valuation, return & balance-sheet ratios
Current values with the period they cover; the trend reads across the 6 fiscal years held (Mar 2021 to Mar 2026).
Financials
Quarterly & annual financial statements
Net profit, year on year: −13% (quarter to sept 2026 against sept 2025).
| Line item | Dec 2024 | Mar 2025 | Jun 2025 | Sept 2025 | Dec 2025 | Mar 2026 | Jun 2026 | Sept 2026 |
|---|---|---|---|---|---|---|---|---|
| 1,417 | 1,452 | 1,478 | 1,552 | 1,574 | 1,670 | 1,848 | 1,877 | |
| 1,193 | 1,229 | 1,242 | 1,284 | 1,327 | 1,389 | 1,454 | 1,630 | |
| 224 | 223 | 236 | 267 | 247 | 281 | 394 | 247 | |
| 16.0% | 15.0% | 16.0% | 17.0% | 16.0% | 17.0% | 21.0% | 13.0% | |
| 19 | 50 | 28 | 50 | 40 | 92 | 35 | 50 | |
| 4 | 5 | 5 | 5 | 4 | 4 | 4 | 4 | |
| 81 | 82 | 82 | 81 | 80 | 79 | 78 | 78 | |
| 158 | 186 | 177 | 231 | 203 | 289 | 347 | 214 | |
| 26.0% | 30.0% | 25.0% | 21.0% | 20.0% | 27.0% | 27.0% | 26.0% | |
| 117 | 130 | 132 | 182 | 164 | 211 | 254 | 159 | |
| 36.93 | 42.97 | 43.40 | 60.88 | 54.60 | 71.38 | 83.32 | 52.89 |
| Line item | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| 5,427 | 4,726 | 5,584 | 6,274 | |
| 4,653 | 4,090 | 4,671 | 5,242 | |
| 774 | 637 | 913 | 1,031 | |
| 119 | 67 | 120 | 210 | |
| 8 | 11 | 23 | 18 | |
| 197 | 243 | 318 | 322 | |
| 687 | 450 | 693 | 900 | |
| 506 | 324 | 499 | 689 |
| Line item | Mar 2023 | Mar 2024 | Mar 2025 | Sept 2025 | Mar 2026 | Sept 2026 |
|---|---|---|---|---|---|---|
| 30 | 29 | 29 | 29 | 29 | 29 | |
| 4,642 | 5,085 | 5,569 | 5,888 | 6,192 | 6,554 | |
| 52 | 237 | 202 | 186 | 183 | 169 | |
| 1,028 | 1,104 | 1,179 | 1,368 | 1,465 | 1,666 | |
| 5,752 | 6,455 | 6,980 | 7,471 | 7,870 | 8,418 | |
| 1,770 | 2,792 | 2,847 | 2,767 | 2,676 | 2,656 | |
| 1,033 | 281 | 124 | 109 | 110 | 122 | |
| 881 | 1,392 | 1,766 | 2,188 | 2,592 | 2,808 | |
| 2,068 | 1,990 | 2,242 | 2,408 | 2,492 | 2,833 | |
| 5,752 | 6,455 | 6,980 | 7,471 | 7,870 | 8,418 |
| Line item | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| 718 | 231 | 707 | 667 | 603 | 1,023 | |
| -645 | -163 | -469 | -683 | -494 | -891 | |
| -52 | -57 | -257 | 38 | -118 | -98 | |
| 21 | 11 | -20 | 22 | -9 | 34 | |
| 396 | -359 | -167 | 164 | 334 | 851 |
| Line item | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|---|---|
| 72 | 71 | 57 | 72 | 74 | 74 | |
| 128 | 122 | 101 | 90 | 97 | 90 | |
| 121 | 90 | 69 | 84 | 82 | 94 | |
| 78 | 103 | 89 | 77 | 89 | 70 | |
| 65 | 77 | 68 | 69 | 77 | 69 | |
| 24.0% | 19.0% | 15.0% | 9.0% | 13.0% | 15.0% | |
| 9.0% | 12.0% | 19.0% | 18.0% | 15.0% | 13.0% |
Where revenue comes from
The businesses behind the company’s reported revenue.
Performance and Other Chemicals contributes 74.2% of reported segment revenue.
Quarter ended 30 Jun 2026 · Consolidated
- Performance and Other Chemicals 74.2%
₹1,427.44 crore
- Life Science Chemicals 24.4%
₹469.23 crore
- Others 1.4%
₹25.98 crore
| Business segment | Revenue · ₹ crore | Share |
|---|---|---|
| Performance and Other Chemicals | 1,427.44 | 74.2% |
| Life Science Chemicals | 469.23 | 24.4% |
| Others | 25.98 | 1.4% |
Share = segment revenue ÷ total segment revenue, before intersegment adjustments.
How these numbers add up
- Total segment revenue
- ₹1,922.65 crore
- Intersegment adjustment
- ₹74.70 crore
- Net segment revenue
- ₹1,847.95 crore
Intersegment transactions are between the company’s own businesses. Net segment revenue can differ from income-statement revenue because reporting definitions differ.
Source: FinEdge · Last checked 19 Sept 2026. Reported segment names are kept as supplied.
How the mix has moved
Life Science Chemicals shrank from 31% to 24% of revenue over the last two years.
| Segment | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Dec 2025 | Mar 2026 | Jun 2026 | YoY growth latest quarter |
|---|---|---|---|---|---|---|---|---|---|
| Performance and Other Chemicals | — | — | — | 70% | 70% | 71% | 72% | 74% | +33.8% |
| Life Science Chemicals | 31% | 28% | 28% | 29% | 29% | 28% | 27% | 24% | +4.5% |
| Others | 1% | 1% | 1% | — | 1% | — | 1% | 1% | +58.8% |
Share of reported segment revenue by quarter, consolidated basis, as filed. A quarter the company did not report is left blank, never carried forward.
See how segments are shifting across companies → Segment Shift
Reverse DCF: growth rate implied by today's share price
ExpensiveTo justify its price of ₹5290, this stock must grow earnings at 15% every year for 7 years. Our analysis caps realistic growth at ~6%. At that growth it is worth ₹3302 — downside of 38%.
- Growth the price implies
- 15.2% a year
- for 7 years, fading to 4%
- It has actually compounded at
- 7.4% a year
- net profit, FY23–FY26 · EPS 6.3%
- The gap
- 0.1 pp
- -38% downside if it only repeats history
Multiples & returns vs own history
Ownership
Who owns it — shareholding pattern
Promoters hold 45.33% as of Sept 2026; institutions added 0.75 pts since Jun 2026.
- Promoters 45.33%
- Foreign institutions 8.90%
- Domestic institutions 25.22%
- Government 0.00%
- Public 20.53%
Who bought this quarter
since Jun 2026
Disclosed holders that added to a position or appeared on the register for the first time, biggest addition first.
- newly disclosed 1.83% held
- Mutual fund +0.41 pp 4.73% held
- Mutual fund +0.13 pp 4.51% held
The same filing shows 1 holder trimming and 1 off the list — both are in the register beside this.
Who is on the register
Named in the Sep 2026 filing
Every holder of Atul Limited above SEBI's 1% disclosure line, and what changed since Jun 2026.
| Holder | Stake | Change |
|---|---|---|
| 22.60% | unchanged | |
| 9.50% | unchanged | |
| Insurer | 5.44% | unchanged |
| Mutual fund | 4.73% | +0.41 pp |
| Mutual fund | 4.51% | +0.13 pp |
| 4.20% | unchanged | |
| Insurer | 3.69% | unchanged |
| 2.10% | unchanged | |
| 1.83% | newly disclosed | |
| 1.58% | unchanged | |
| 1.55% | unchanged | |
| Insurer | 1.04% | −0.13 pp |
A holder disappearing from this list has fallen below the 1% line — it is not necessarily a sale. Percentages are of total shares, as disclosed in the company's own filing. Who was buying across the market this quarter.
Mutual funds in ATUL
Filings to Sep 2026
1 new, 0 added, 5 trimmed, 0 sold out — net +1.60 L shares (+391.5%).
- Held by funds
- ₹119 Cr
- 7 schemes
- Biggest holder
- HDFC Aggressive Hybrid Fund
- ₹95 Cr · 0.5% of that fund
| Scheme | Holding | Last month | Held since |
|---|---|---|---|
| HDFC Aggressive Hybrid Fund HDFC Mutual Fund | ₹95 Cr | new | Sep '26 |
| Nippon India Nifty Smallcap 250 Index Fund Nippon India Mutual Fund | ₹15 Cr | −0.01 L | Sep '24 |
| SBI Nifty Smallcap 250 Index Fund SBI Mutual Fund | ₹7 Cr | −0.00 L | Sep '24 |
| Nippon India Nifty 500 Equal Weight Index Fund Nippon India Mutual Fund | ₹1 Cr | −0.00 L | Sep '24 |
| SBI Nifty 500 Index Fund SBI Mutual Fund | ₹0 Cr | −0.00 L | Sep '24 |
| HDFC Large & Mid Cap Fund HDFC Mutual Fund | ₹0 Cr | held | Dec '22 |
| SBI Nifty Small Cap 250 ETF SBI Mutual Fund | ₹0 Cr | −0.00 L | May '26 |
HDFC, Nippon India and SBI schemes, from their monthly disclosures. Changes are counted in shares, so a price move never looks like buying or selling.
Mutual funds Sep 2026
0 added, 5 trimmed — net +1.60 L shares (+391.5%)
- Funds are sitting on
- -14%
- vs est. average cost
- Held by funds
- ₹119 Cr
- 7 schemes · ≈ 0.68% of the company
- Biggest holder
- HDFC Aggressive Hybrid Fund
- ₹95 Cr · 0.5% of that fund
- Longest holder
- HDFC Large & Mid Cap Fund
- 3y 10m · since Dec '22
Shares held by these funds −72%
Oct '23 2.00 L shares Sep '26
Your own record
Start an Inve Case for Atul Limited
Free account: one company. Everything above stays public.
Write why you follow Atul Limited and the condition you want checked. Inve compares your numeric conditions with available results and management guidance; your own conditions remain yours to review.
Keep reading
Other Chemicals companies
- AA
AARTIINDAarti Industries Limited - SU
SUMICHEMSumitomo Chemical India Limited - BA
BAYERCROPBayer Cropscience Limited - CH
CHAMBLFERTChambal Fertilizers & Chemicals Limited - TA
TATACHEMTata Chemicals Limited - DE
DEEPAKFERTDeepak Fertilizers and Petrochemicals Corporation Limited - PA
PARADEEPParadeep Phosphates Limited - AN
ANURASAnupam Rasayan India Limited
Quick Answers
Frequently asked questions on Atul Limited
Compiled directly from ATUL's filed financial statements, earnings call transcripts, and ownership disclosures.
How did Atul Limited (ATUL) perform in its latest reported quarter (Sept 2026)?
For the quarter ended Sept 2026, Atul Limited reported revenue of ₹1.9k Cr, net profit of ₹159 Cr, an operating margin of 13.0%. Diluted earnings per share stood at ₹52.89.
How is Atul Limited (ATUL) valued today, and what growth does the stock price imply?
Atul Limited (ATUL) trades at ₹5,290, with a market capitalization of ₹15.6k Cr. Reverse-DCF analysis shows the current stock price implies 15.2% annual earnings growth over the next 7 years compared with its historical net-profit CAGR of 7.4%.
Who owns Atul Limited (ATUL) — promoters, FIIs, DIIs, and mutual funds?
As of Sept 2026, Promoters hold 45.3%, FIIs hold 8.9%, DIIs hold 25.2%, Public shareholders hold 20.5%.
Learn to analyse Atul Limited
Guides on how to read this kind of business and the numbers that matter.